Published in J Virol on August 28, 2013
Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function. J Virol (2013) 0.85
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. J Virol (2015) 0.82
The Cell Cycle Timing of Human Papillomavirus DNA Replication. PLoS One (2015) 0.79
Could the human papillomavirus vaccines drive virulence evolution? Proc Biol Sci (2015) 0.78
The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome. Virol J (2015) 0.77
Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci Rep (2015) 0.76
Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency. PLoS One (2015) 0.76
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay. PLoS Pathog (2017) 0.75
Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma. Mol Cancer Res (2016) 0.75
DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells. Virol J (2015) 0.75
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med (1953) 25.88
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J (1991) 6.00
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature (2002) 3.99
Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J (1991) 3.98
Homologous recombination in DNA repair and DNA damage tolerance. Cell Res (2008) 3.86
Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci U S A (1992) 3.58
Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer (1989) 3.30
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci U S A (1993) 3.26
Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology (1985) 3.22
Isolation of human sequences that replicate autonomously in human cells. Mol Cell Biol (1989) 3.16
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol (1991) 3.10
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci U S A (1993) 2.35
The human papillomavirus E7 oncoprotein. Virology (2008) 2.32
Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog (2009) 2.21
A causal role for human papillomavirus in head and neck cancer. Lancet (2004) 2.21
Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature (1991) 2.09
LONG-TERM CULTIVATION OF HYPODIPLOID HUMAN TUMOR CELLS. J Natl Cancer Inst (1964) 2.09
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther (2005) 2.06
Knotted single-stranded DNA rings: a novel topological isomer of circular single-stranded DNA formed by treatment with Escherichia coli omega protein. J Mol Biol (1976) 2.05
In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol (1991) 2.00
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00
A robust system for production of minicircle DNA vectors. Nat Biotechnol (2010) 1.95
Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol (1997) 1.92
Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med (1970) 1.80
The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J Virol (1998) 1.77
Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol (1994) 1.70
Papillomavirus E6 proteins. Virology (2008) 1.70
The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol (1993) 1.67
Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62
Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J Virol (1997) 1.61
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol (1997) 1.59
Assembly of a double hexameric helicase. Mol Cell (2005) 1.59
Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol Cell (2000) 1.52
The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol (2011) 1.49
Escherichia coli DNA topoisomerase I catalyzed linking of single-stranded rings of complementary base sequences. Nucleic Acids Res (1978) 1.46
Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. EMBO J (2002) 1.45
The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res (1992) 1.38
Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37
Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res (2002) 1.34
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34
Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33
Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J Virol (1989) 1.30
DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin. J Virol (1999) 1.29
Evidence that replication initiates at only some of the potential origins in each oligomeric form of bovine papillomavirus type 1 DNA. Mol Cell Biol (1990) 1.28
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol (1995) 1.21
Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol (2002) 1.21
Topological complexity of different populations of pBR322 as visualized by two-dimensional agarose gel electrophoresis. Nucleic Acids Res (1998) 1.15
Papillomavirus DNA replication - from initiation to genomic instability. Virology (2009) 1.15
Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14
Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology (1993) 1.12
Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol (2011) 1.11
Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS (2010) 1.11
The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology (1995) 1.10
Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol (2001) 1.08
Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J Med Virol (1987) 0.99
Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J Virol (2011) 0.96
Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol Oncol (1993) 0.96
The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95
Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology (2010) 0.93
The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol (2011) 0.90
Rolling-circle replication of a high-copy BPV-1 plasmid. J Mol Biol (1992) 0.86
Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs. J Clin Microbiol (1996) 0.85
Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol (2006) 1.47
Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia. Scand J Infect Dis (2007) 1.43
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line. BMC Mol Biol (2002) 1.39
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J Virol (2004) 1.29
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Papillomavirus DNA replication - from initiation to genomic instability. Virology (2009) 1.15
Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14
Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res (2005) 1.14
Predominance of a rare type of HIV-1 in Estonia. J Acquir Immune Defic Syndr (2005) 1.02
Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J Virol (2005) 0.99
Association of cagA and vacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J Clin Microbiol (2002) 0.98
Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates. Hum Gene Ther (2009) 0.97
Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J Virol (2011) 0.96
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Viral Immunol (2005) 0.94
Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology (2010) 0.93
Identification and analysis of papillomavirus E2 protein binding sites in the human genome. J Virol (2011) 0.90
Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J Virol (2002) 0.90
RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog (2013) 0.88
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies. Microbes Infect (2005) 0.87
Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function. J Virol (2013) 0.85
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects. Vaccine (2012) 0.85
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. Vaccine (2009) 0.84
Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol (2005) 0.83
New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochim Biophys Acta (2013) 0.83
Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers. J Virol (2006) 0.81
Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology (2009) 0.81
Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2008) 0.81
Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division. J Virol (2010) 0.81
Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. AIDS Res Hum Retroviruses (2006) 0.79
Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res (2003) 0.78
DNA Transfer into Animal Cells Using Stearylated CPP Based Transfection Reagent. Methods Mol Biol (2015) 0.78
High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2007) 0.77
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line: Correction. BMC Mol Biol (2002) 0.75
Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS. Nucleus (2015) 0.75
CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts. APMIS (2007) 0.75
Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures. Plasmid (2003) 0.75
Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127. Chem Biol Interact (2006) 0.75
Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies. Melanoma Res (2003) 0.75